Institute for Cancer Research
Donations deductibleInstitute for Cancer Research's network
15 people7 organisationsi15 people and 7 organisations on this map.The large node is the subject of this page. Solid lines are what the register itself records (15). Violet dotted lines (42) are likely: the same full name sits on the current board of another organisation in the same register and region. Form 990 filings give names without a person identifier; SEC insider filings carry a CIK. It may be a different person.The board
15 listediTime on the board is observed from the annual filings: the IRS files no appointment date, so the bar counts years from the first filing the person appears on - a lower bound, not a filed start date. Names are exactly as filed. The IRS publishes no person identifier, so this edition does not yet link a person across organisations in the tables. The network map shows same-name matches as likely links only, never as confirmed.Tenure and departures are observed across annual filings. Observed tenure is a lower bound - a member may have joined before the first year on record. The organisation reported 15 voting members of its governing body on its latest Form 990 Part VI, which matches the board listed here.| Name | Role as filed | Since | On the board |
|---|---|---|---|
| Lewis Gould Chair | Director/Chair | 2018 | 8 yrs |
| Amy Goldberg | Director | 2023 | 3 yrs |
| Chip W Marshall III | Director | 2021 | 5 yrs |
| Christopher McNichol | Director/Vice Chair | 2018 | 8 yrs |
| Carl Sottosanti | Director | 2022 | 4 yrs |
| David Marshall | Director | 2018 | 8 yrs |
| Dr Donald Morel (also filed as Dr Donald Morel) | Director | 2018 | 8 yrs |
| Dr Solomon LUO (also filed as Dr Solomon Luo) | Director | 2018 | 8 yrs |
| Edward Glickman | Director | 2018 | 8 yrs |
| Leon O Moulder | Director | 2018 | 8 yrs |
| Michael Young | Director | 2020 | 6 yrs |
| Sandra Harmon-Weiss | Director | 2018 | 8 yrs |
| Thomas Hofmann | Director | 2018 | 8 yrs |
| Tina Pidgeon | Director | 2022 | 4 yrs |
| William Federici | Director | 2018 | 8 yrs |
Officers and senior leadership
25 listediNamed in Part VII as officers, key employees or highest-compensated staff - not board members, shown for completeness.| Name | Title as filed | On the filings |
|---|---|---|
| Beth Koob | Secretary (until 11/24/21) | since 2018 |
| Carmel Vahey | Company secretary | since 2018 |
| Charna Wright | Asst Secretary | since 2018 |
| Dr J Robert Beck | Chief Academic Officer | since 2018 |
| Dr Richard I Fisher | President & CEO | since 2018 |
| David Wiest | Chief Scientific Officer | since 2022 |
| Dr Robert Uzzo | President & CEO | since 2022 |
| Efrat Dotan | Associate Professor / MD | since 2022 |
| James L Helstrom MD | Chief Medical Officer | since 2021 |
| Jonathan Chernoff | Chief Science Officer | since 2018 |
| Jose Russo | Director of the Fox Chase Breast Cancer Research L | 2021 |
| Judith Bachman | COO & Asst Treasurer | since 2018 |
| Jarred Matchett | Treasurer & CFO | 2023 |
| Jerome Maddox | Company secretary | 2023 |
| John Ryan | Secretary (from 02/16/22 // until 10/26/22) | since 2022 |
| Johnathon Whetstine | Professor | 2020 |
| Mary Daly | Chair Clinical Genetics | since 2018 |
| Michael Difranco | Assistant Treasurer | since 2021 |
| Michael Hall | Professor | since 2018 |
| Paul Engstrom | Chair Medical Oncology | since 2018 |
| Ray Lynch | Treasurer & CFO (until 04/09/22) | since 2018 |
| Robert Lux | Asst Treasurer | since 2018 |
| Shawn Paul Kleitz | Chief Development Officer | since 2020 |
| Tausha Saunders | Assistant Secretary (from 10/20/22) | 2023 |
| Wafik El-Deiry | Translational Research | since 2018 |
Pay and hours
year to 30 June 2025iFrom Part VII of the Form 990: compensation reported for each officer, director, trustee, key employee and highest-paid staff member, and the average hours a week they report. Most board members are unpaid; a blank means nothing was reported. Pay from related organisations is shown separately.| Name | Title as filed | Hours a week | Pay from the organisation | Related organisations | Other |
|---|---|---|---|---|---|
| Jonathan Chernoff | Cancer Center Director | 49 | $858k | $69k | |
| David Wiest | Chief Scientific Officer | 50 | $624k | $67k | |
| Michael Hall | Professor | 50 | $493k | $58k | |
| Elizabeth Plimack | Professor | 50 | $491k | $67k | |
| Siddharth Balachandran | Professor | 50 | $489k | $54k | |
| Shawn Paul Kleitz | Chief Development Officer | 50 | $353k | $47k | |
| Carolyn Fang | Professor | 50 | $348k | $28k | |
| Mary Daly | Professor | 50 | $328k | $46k | |
| Lewis Gould | Director | 1 | $0 | ||
| Chip W Marshall III | Director/Chair | 1 | $0 | ||
| Christopher McNichol | Director/Vice Chair | 1 | $0 | ||
| Michael Young | Director | 1 | $0 | $2.1m | $42k |
| Amy Goldberg | Director | 1 | $0 | $1.2m | $56k |
| Tina Pidgeon | Director | 1 | $0 | ||
| Dr Solomon Luo | Director | 1 | $0 | ||
| Edward Glickman | Director | 1 | $0 | ||
| Thomas Hofmann | Director | 1 | $0 | ||
| David Marshall | Director | 1 | $0 | ||
| Dr Donald Morel | Director | 1 | $0 | ||
| William Federici | Director | 1 | $0 | ||
| Sandra Harmon-Weiss | Director | 1 | $0 | ||
| Leon O Moulder | Director | 1 | $0 | ||
| Carl Sottosanti | Director | 1 | $0 | ||
| Dr Robert Uzzo | President & CEO | 1 | $0 | $1.5m | $73k |
| John Ryan | Asst Secretary | 1 | $0 | $841k | $51k |
| Tausha Saunders | Asst Secretary | 1 | $0 | $190k | $375 |
| Amy Montour | Asst Secretary | 1 | $0 | $18k | |
| Jerome Maddox | Secretary | 1 | $0 | $491k | $44k |
| Jarred Matchett | Treasurer & CFO | 1 | $0 | $427k | $45k |
| Michael DiFranco | Asst Treasurer | 1 | $0 | $382k | $51k |
| Timothy Cyphers | Asst Treasurer | 1 | $0 | $166k | $36k |
Colorado roster
33 listediOfficers, directors and trustees from the latest filing with the Colorado Secretary of State (document 20263021422). Titles are as filed; some entries are registered agents or custodians of records rather than board members. Source: data.colorado.gov, public domain.| Name | Title as filed |
|---|---|
| David Wiest | Chief Scientific Officer |
| Carl Sottosanti | Director |
| Michael Hall | Professor |
| Robert Uzzo, MD, MBA, Facs | President & CEO |
| Michael Difranco | Assistant Treasurer |
| Mary Daly | Professor |
| Amy Montour | Assistant Secretary |
| John Ryan | Assistant Secretary |
| Christopher McNichol | Vice Chair |
| Jerome Maddox | Secretary |
| Siddarth Balachandran | Professor |
| Edward Glickman | Director |
| Dr. Solomon Luo | Director |
| Timothy Cyphers | Assistant Treasurer |
| Dr. Robert Uzzo | President & CEO |
| Thomas Hofmann | Director |
| Carolyn Fang | Professor |
| Leon O. Moulder | Director |
| Jarred Matchett | |
| David Marshall | Director |
| Sandra Harmon-Weiss | Director |
| Elizabeth Plimack | Professor |
| Chip W. Marshall, III | Chair |
| Amy Goldberg | Director |
| William Federici | Director |
| Jonathan Chernoff | Cancer Center Director |
| Tausha Saunders | Assistant Secretary |
| Tina Pidgeon | Director |
| Shawn Paul Kleitz | Chief Development Officer |
| Dr. Donald Morel | Director |
| Jarred Matchett | Treasurer & CFO |
| Lewis Gould | Director |
| Michael Young | Director |
About
- Legal name
- Institute for Cancer Research
- EIN
- 236296135
- Address
- 3509 N Broad Street Rm 936, Philadelphia, PA, 19140-4105
- State
- Pennsylvania
- Mission
- To prevail over cancer, marshaling heart and mind in bold scientific discovery, pioneering prevention and compassionate care. (as filed on the Form 990)
- Activity (NTEE)
- H300 Medical research
- IRS classification
- 501(c)03 (tax-exempt under section 501(c)(3) where shown)
- Classified purpose
- Medical Research
- Size band
- 9 (IRS master file code)
- Formed
- 1944
- Principal officer
- Michael DiFranco (as named on the Form 990)
- IRS ruling date
- 1 December 1944
- Status
- Code 01 (unconditional exemption)
- Form 990 filings on record
- 6, latest 2023
- IRS Publication 78
- PC (contributions deductible)
Most connected
Related organisations (Schedule R)
RelatedEducationTemple University of the Commonwealth System of Higher EdRelatedHealth CareTemple University Health System IncRelatedHealth CareTemple University Hospital IncRelatedHealth CareTemple Physicians Inc
Longest observed on the filings
≥8years on the filingsLewis Gould
≥8years on the filingsChristopher McNichol
≥8years on the filingsDavid Marshall
≥8years on the filingsDr Donald Morel
Latest return
year to 30 June 2025iFigures from the newest Form 990 or 990-EZ in the IRS e-file releases of 2025 and 2026, for the year ending 30 June 2025. US dollars, as filed.- Total assets
- $192m
- Total liabilities
- $81.8m
- Net assets or fund balances
- $110.2m
- Contributions and grants received
- $42.6m
- Program service revenue
- $51.2m
- Grants and similar paid out
- $548k
- Employees
- 776
- Volunteers
- 13
Grants paid
2 listediFrom Schedule I of the Form 990: grants and assistance to organisations in the United States, largest first (up to 25). Schedule I is filed only by organisations that gave more than $5,000 to any one recipient.| Recipient | Purpose | Amount |
|---|---|---|
| Fox Chase Cancer Center Medical Group Inc | General Support | $455k |
| The American Oncologic Hospital | General Support | $93k |